ARYx Therapeutics: new drugs with the
efficacy of proven therapies and significantly better safety
profiles. ARYx was founded in 1997 by Peter Milner, M.D. and
Pascal Druzgala, Ph.D. ARYx’s proprietary ARM™ (ARYx
RetroMetabolic) technology analyzes the parent structure and
degradation products of known drugs and creates new drug
candidates that use different metabolic pathways for
clearance.
